View Author
patient adherence study treatment ga adherence netherland contact discontinuation number sclerosis neurologist copaxone month stroke heeft health disease research event jongen ga treatment therapy factor anticoagulant duration health care antiplatelet therapy quantity antiplatelet trial neurology information outcome ms-nurse questionnaire self-efficacy glatiramer acetate multidisciplinary care 12 months review prevention quality discipline ischemic origin dutch van gijn j cochrane caregiver ischemic attack vindt relapse report characteristic care sessions adherence-related factors nurse score behandeling study website glatiramer relapsing infarction algra acetate measure discontinuation risk score ischemia attack anticoagulation nijmegen swets subs service ziekenhui disability cochrane library aspirin rrms patients .... min medication voldoende
2 Most Recent Publications
|
Drug adherence and multidisciplinary care in patients with multiple sclerosis: Protocol of a prospective, web-based, patient-centred, nation-wide, Dutch cohort study in glatiramer acetate treated patients (CAIR study)
(Article)
Jongen, P.J. Hengstman, G. Schryver, E.L.L.M. De Siepman, T.A.M. Tonk, M. Zandbergen, E. Holter, J. ten Kruijk, R. van der Borm, G. Hupperts, R. Schrijver, H. Gilhuis, J. Vliegen, J.H. Hoogervorst, E. Huizen, M. van Munster, E. van Samijn, J. |
2011-03-30
|
|
Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischemic attack or minor stroke of presumed arterial origin
(Article)
Algra, A. Schryver, E.L.L.M. De Gijn, J. van Kappelle, L.J. Koudstaal, P.J. |
2003-01-01
|
